Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Trends in Cancer
|
December 10, 2021
Impact of tissue-agnostic approvals for patients with sarcoma
Roberto Carmagnani Pestana, Juliana Rodrigues Beal, Amanda Parkes, et al.
Journal of Oncology Practice
|
June 22, 2019
Standardizing Opioid Prescribing Practices for Cancer-Related Pain Via a Novel Interactive Documentation Template at a Public Hospital
Maliha Nusrat, Amanda Parkes, Ryan Kieser, et al.
JCO Oncology Practice
|
April 14, 2021
Disparities Between Provider Assessment and Documentation of Care Needs in the Care of Adolescent and Young Adult Patients With Sarcoma
Grace E McKay, Anna L Zakas, Fauzia Osman, et al.
Journal of Adolescent and Young Adult Oncology
|
August 15, 2023
A Midwest Stakeholder Evaluation of an Adolescent and Young Adult Cancer Survivor Needs Assessment Survey
Cathy Lee-Miller, Kathleen E Montgomery, Jane Evered, et al.
Journal of Palliative Medicine
|
April 29, 2016
Quality of Life, Mood, and Prognostic Understanding in Patients with Metastatic Breast Cancer
Jennifer A Shin, Areej El-Jawahri, Amanda Parkes, et al.
Palliative Medicine
|
March 17, 2016
Retrospective evaluation of palliative care and hospice utilization in hospitalized patients with metastatic breast cancer
Jennifer A Shin, Amanda Parkes, Areej El-Jawahri, et al.
NPJ Breast Cancer
|
February 2, 2018
Characterization of bone only metastasis patients with respect to tumor subtypes
Amanda Parkes, Katherine Clifton, Aydah Al-Awadhi, et al.
Clinical Pharmacokinetics
|
April 22, 2025
Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer
Stephanie Kong, Mukul Minocha, Po-Wei Chen, et al.
Clinical Pharmacokinetics
|
November 26, 2024
Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE<sup>®</sup>) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation Study
Mukul Minocha, Corbin G Thompson, Alexis Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2025
Tarlatamab Exposure-Efficacy and Exposure-Safety Relationships to Inform Dose Selection in Patients with Small Cell Lung Cancer
Po-Wei Chen, Mukul Minocha, Stephanie Kong, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Trends in Cancer
|
December 10, 2021
Impact of tissue-agnostic approvals for patients with sarcoma
Roberto Carmagnani Pestana, Juliana Rodrigues Beal, Amanda Parkes, et al.
Journal of Oncology Practice
|
June 22, 2019
Standardizing Opioid Prescribing Practices for Cancer-Related Pain Via a Novel Interactive Documentation Template at a Public Hospital
Maliha Nusrat, Amanda Parkes, Ryan Kieser, et al.
JCO Oncology Practice
|
April 14, 2021
Disparities Between Provider Assessment and Documentation of Care Needs in the Care of Adolescent and Young Adult Patients With Sarcoma
Grace E McKay, Anna L Zakas, Fauzia Osman, et al.
Journal of Adolescent and Young Adult Oncology
|
August 15, 2023
A Midwest Stakeholder Evaluation of an Adolescent and Young Adult Cancer Survivor Needs Assessment Survey
Cathy Lee-Miller, Kathleen E Montgomery, Jane Evered, et al.
Journal of Palliative Medicine
|
April 29, 2016
Quality of Life, Mood, and Prognostic Understanding in Patients with Metastatic Breast Cancer
Jennifer A Shin, Areej El-Jawahri, Amanda Parkes, et al.
Palliative Medicine
|
March 17, 2016
Retrospective evaluation of palliative care and hospice utilization in hospitalized patients with metastatic breast cancer
Jennifer A Shin, Amanda Parkes, Areej El-Jawahri, et al.
NPJ Breast Cancer
|
February 2, 2018
Characterization of bone only metastasis patients with respect to tumor subtypes
Amanda Parkes, Katherine Clifton, Aydah Al-Awadhi, et al.
Clinical Pharmacokinetics
|
April 22, 2025
Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer
Stephanie Kong, Mukul Minocha, Po-Wei Chen, et al.
Clinical Pharmacokinetics
|
November 26, 2024
Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE<sup>®</sup>) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation Study
Mukul Minocha, Corbin G Thompson, Alexis Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2025
Tarlatamab Exposure-Efficacy and Exposure-Safety Relationships to Inform Dose Selection in Patients with Small Cell Lung Cancer
Po-Wei Chen, Mukul Minocha, Stephanie Kong, et al.
Page
of 4